North America: Lucrative market for opportunities for glufosinate

By -

Glufosinate Market by Crop Type (Genetically Modified Crops, Conventional Crops), Form (Liquid Formulation, Dry Formulation), Application (Agricultural, Non Agricultural), and Region - Global Forecast to 2022

(EMAILWIRE.COM, August 05, 2020 ) The global glufosinate market is projected to grow at a CAGR of 9.25% to reach USD 2.34 Billion by 2022 in terms of value. The objective of this study is to define, segment, and project the size of the glufosinate market on the basis of crop type, form, application, and region, and to provide detailed information about the crucial factors influencing market dynamics (drivers, restraints, opportunities, and industry-specific challenges). The market opportunities and competitive landscape of market leaders are also studied for the stakeholders. Competitive developments such as new product launches, expansions, and investments are also included.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191789620

Market Ecosystem

The various contributors involved in the value chain of the glufosinate market include pesticide manufacturers, importers & exporters, traders, distributors, suppliers, and consumers which include farmers. The value chain comprises key manufacturers in the glufosinate market, such as Bayer AG (Germany), The Dow Chemical Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), Syngenta AG (Switzerland), and UPL (India), which have diversified product portfolios, proprietary technologies, and strong distribution networks and offices at strategic locations across the globe. These companies focus on innovation and enhancing the functional and physiological properties of glufosinate products and cater to the growing demand in the glufosinate industry. Other players in this market are Nufarm Ltd (Australia), Jiangsu Huangma Agrochemicals Co, Ltd. (China), Jiangsu Sevencontinent Green Chemical Co., Ltd. (China), Hebei Veyong Bio-Chemical Co., Ltd. (China), and Zhejiang Yongnong Chem. Ind. Co. Ltd. (China), which also have a strong presence in the market. Glufosinate production has increased in recent years in China for catering to the growing demand across globe.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=191789620

North America: Lucrative market for opportunities for glufosinate

In 2015, the North American region accounted for the largest share of the global glufosinate market in terms of value and volume. The glufosinate market in North America is also projected to grow at a significant CAGR during the forecast period. This region comprises developed economies such as U.S. and Canada, where the U.S. is a key producer of various agricultural applications. There is growing awareness observed in the U.S. with regard to glufosinate products. Glufosinate is registered for use in crops such as almonds, apples, bananas, berries, canola, corn, cotton, grapes, potatoes, rice, soybean, and tree nuts in the U.S. which has resulted in the growth of the market in this region.

This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It includes the profiles of leading companies such as Bayer AG (Germany), The Dow Chemical Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), Syngenta AG (Switzerland), and UPL (India).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

Media Contact

Related Tags

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more